Gilead to Buy Kite, Maker of Cancer Treatments, for $11.9 Billion

Photo of Gilead to Buy Kite, Maker of Cancer Treatments, for $11.9 Billion
Facebook
VKontakte
share_fav

The deal to acquire Kite, whose drugs use the body’s immune system as a weapon, is Gilead’s biggest effort to date to find a new blockbuster product.

view The New York Times: Health
#mergers acquisitions and divestitures
#drugs pharmaceuticals
#gilead sciences inc
#kite pharma inc